The Bayesian basket design for genomic variant-driven phase II trials

Seminars in Oncology

Volumn 43, Issue 1, 2016, Pages 13-18

  Simon, Richard ^a   Geyer, Susan ^b   Subramanian, Jyothi ^c   Roychowdhury, Sameek ^d  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c EMMES CORPORATION   (United States)

^d OHIO STATE UNIVERSITY   (United States)

Author keywords

Actionable mutations; Basket clinical trials; Genomic clinical trials

Indexed keywords

ARTICLE; BAYES THEOREM; CANCER GENETICS; CANCER PATIENT; COMPUTER SIMULATION; DRUG ACTIVITY; GENETIC VARIABILITY; HISTOPATHOLOGY; PATIENT MONITORING; PHASE 2 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; TREATMENT PLANNING; TREATMENT RESPONSE; COMPUTER PROGRAM; GENETIC VARIATION; GENETICS; GENOMICS; HUMAN; INTERNET; MEDICAL RESEARCH; METHODOLOGY; NEOPLASMS; PATHOLOGY; PROCEDURES;

BAYES THEOREM; BIOMEDICAL RESEARCH; CLINICAL TRIALS, PHASE II AS TOPIC; COMPUTER SIMULATION; GENETIC VARIATION; GENOMICS; HUMANS; INTERNET; NEOPLASMS; RESEARCH DESIGN; SOFTWARE;

EID: 84960348344     PISSN: 00937754     EISSN: 15328708     Source Type: Journal    
DOI: 10.1053/j.seminoncol.2016.01.002     Document Type: Article

References (9)

1. R. Simon Genomic clinical trials and predictive medicine 2013 Cambridge University Press Boston, MA
2. R. Simon, and S. Roychowdhury Implementing personalized cancer genomics in clinical trials Nat Rev Drug Disc 12 2013 358 369
3. R. Simon, and E. Polley Clinical trials for precision oncology using next generation sequencing Personal Med 10 2013 485 495
4. B. Freidlin, and E.L. Korn Borrowing information across subgroups in phase II trials: is it useful Clin Cancer Res 19 2013 1326 1334
5. E.S. Kim, R.S. Herbst, L.J.J. Wistuba, and et al. The BATTLE trial: personalizing therapy for lung cancer Cancer Disc 1 2011 44 53
6. R. Simon Optimal two-stage designs for phase II clinical trials Control Clin Trials 10 1989 1 10
7. D.M. Hyman, I. Puzanov, V. Subbiah, and et al. Vemurafenib in multiple nonmelanoma cancers with BRAF V600 mutations N Engl J Med 373 2015 726 736
8. M. LeBlanc, C. Rankin, and J. Crowley Multiple histology phase II trials Clin Cancer Res 15 2009 4256 4262
9. P.F. Thall, B.N. Bekele, R.E. Champlin, L.H. Baker, and R.S. Benjamin Hierarchical Bayesian approaches to phase II trials in diseases with multiple subtypes Stat Med 22 2003 27 36